We are live on ! Find out more
Alkeon Capital Management

Alkeon Capital Management Portfolio holdings

AUM $59.5B
1-Year Est. Return 51.63%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$15.4B
AUM Growth
-$5.77B
Cap. Flow
-$3.14B
Cap. Flow %
-20.4%
Top 10 Hldgs %
46.99%
Holding
144
New
21
Increased
30
Reduced
61
Closed
26

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$88.3M
2
TWTR
Twitter, Inc.
TWTR
+$77.9M
3
DLTR icon
Dollar Tree
DLTR
+$77.1M
4
ADI icon
Analog Devices
ADI
+$73M
5
MSFT icon
Microsoft
MSFT
+$67.8M

Sector Composition

Rank Sector Weight
1 Technology 17.89%
2 Communication Services 6.61%
3 Consumer Discretionary 5.44%
4 Financials 5.2%
5 Industrials 3.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMU
101
DELISTED
Immunomedics Inc
IMMU
$18.8M 0.12%
1,316,975
-683,260
-34% -$13.6M
PLAN
102
DELISTED
Anaplan, Inc.
PLAN
$18M 0.12%
+679,854
New +$16.8M
FTCH
103
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$17.7M 0.12%
1,000,000
-400,352
-29% -$8.67M
XLRN
104
DELISTED
Acceleron Pharma
XLRN
$16.3M 0.11%
373,950
+101,621
+37% +$5.08M
TENB icon
105
Tenable Holdings
TENB
$4.01B
$13.7M 0.09%
615,563
-284,542
-32% -$8.08M
ALNY icon
106
Alnylam Pharmaceuticals
ALNY
$29.3B
$12.4M 0.08%
+170,000
New +$13.1M
BPMC
107
DELISTED
Blueprint Medicines
BPMC
$12.1M 0.08%
+224,346
New +$13.6M
DCPH
108
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$10.5M 0.07%
498,547
+123,547
+33% +$3.04M
DLTR icon
109
Dollar Tree
DLTR
$25.2B
$9.36M 0.06%
103,649
-912,784
-90% -$77.1M
VIPS icon
110
CALL
Vipshop
VIPS
$7.53B
$4.91M 0.03%
900,000
AYX
111
DELISTED
Alteryx Inc
AYX
$2.97M 0.02%
50,000
AMAT icon
112
CALL
Applied Materials
AMAT
$428B
$2.46M 0.02%
+75,000
New +$2.57M
SINA
113
CALL
DELISTED
Sina Corp
SINA
$2.15M 0.01%
40,000
IBB icon
114
iShares Biotechnology ETF
IBB
$9.77B
$1.45M 0.01%
+15,000
New +$1.59M
MOMO
115
CALL
Hello Group
MOMO
$866M
$1.19M 0.01%
+50,000
New +$1.57M
PYPL icon
116
PayPal
PYPL
$50.5B
$1.12M 0.01%
13,281
STML
117
DELISTED
Stemline Therapeutics, Inc.
STML
$665K ﹤0.01%
70,000
+30,000
+75% +$389K
COST icon
118
Costco
COST
$420B
$554K ﹤0.01%
2,722
AAPL icon
119
Apple
AAPL
$4.57T
-26,800
Closed -$1.3M
ABEO icon
120
Abeona Therapeutics
ABEO
$413M
-2,460
Closed -$787K
ADVM
121
DELISTED
Adverum Biotechnologies
ADVM
-81,871
Closed -$4.95M
ALDX icon
122
Aldeyra Therapeutics
ALDX
$93.5M
-85,000
Closed -$1.17M
ARGX icon
123
argenx
ARGX
$54.1B
-12,470
Closed -$946K
BUD icon
124
PUT
AB InBev
BUD
$165B
-500,000
Closed -$43.8M
EA
125
CALL
DELISTED
Electronic Arts
EA
-600,000
Closed -$72.3M

Similar funds

Alkeon Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Alkeon Capital Management held 144 positions worth $15.4B, down 27% from $21.1B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Alkeon Capital Management withdrew a net $3.14B in Q4 2018, closing 26 positions and reducing 61 holdings. Its most notable exit was TSMC, an estimated $88.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, Alkeon Capital Management opened a new position in Las Vegas Sands worth $96M.

  • Alkeon Capital Management's largest Q4 2018 buy was Las Vegas Sands: 1,844,138 shares worth $96M.
  • Alkeon Capital Management added most to Activision Blizzard in Q4 2018, an estimated $68.1M increase.
  • Alkeon Capital Management's biggest Q4 2018 reduction was Dollar Tree, cutting an estimated $77.1M.
  • Alkeon Capital Management fully exited TSMC in Q4 2018, selling an estimated $88.3M.
  • Alkeon Capital Management's ten largest holdings make up 47% of its $15.4B portfolio in Q4 2018.
  • Alkeon Capital Management opened 21 new positions and closed 26 in Q4 2018.
  • Alkeon Capital Management's portfolio value fell 27% quarter-over-quarter to $15.4B.

Based on Alkeon Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.